BARCELONA, Spain and DÜSSELDORF, Germany, July 24, 2026 -- Minoryx Therapeutics and Neuraxpharm Group, announce that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has...
Art Pappas will participate on a panel called "Venture Capital and Private Equity - How Do You Look for the Next Big Investment" at the Drug Delivery Partnerships conference in Las Vegas, NV
News | 01. 22. 2009
